IDEXX Laboratories, Inc. (0J8P.L)
USD 419.98
(-2.66%)
USD 419.98
(-2.66%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 947.88 Million USD | -29.7% |
| 2022 | 1.34 Billion USD | 45.97% |
| 2021 | 923.7 Million USD | 1.68% |
| 2020 | 908.48 Million USD | -8.02% |
| 2019 | 987.67 Million USD | -1.26% |
| 2018 | 1 Billion USD | -20.68% |
| 2017 | 1.26 Billion USD | 4.73% |
| 2016 | 1.2 Billion USD | 2.91% |
| 2015 | 1.17 Billion USD | 30.15% |
| 2014 | 899 Million USD | 109.85% |
| 2013 | 428.39 Million USD | 99.72% |
| 2012 | 214.5 Million USD | -12.95% |
| 2011 | 246.41 Million USD | 84.89% |
| 2010 | 133.28 Million USD | 7.58% |
| 2009 | 123.88 Million USD | -20.83% |
| 2008 | 156.47 Million USD | 98.87% |
| 2007 | 78.68 Million USD | 1004.32% |
| 2006 | 7.12 Million USD | 1193.1% |
| 2005 | 551 Thousand USD | -67.26% |
| 2004 | 1.68 Million USD | 31.48% |
| 2003 | 1.28 Million USD | 31.55% |
| 2002 | 973 Thousand USD | -88.39% |
| 2001 | 8.38 Million USD | -1.09% |
| 2000 | 8.47 Million USD | 135.33% |
| 1999 | 3.6 Million USD | -61.7% |
| 1998 | 9.4 Million USD | 129.27% |
| 1997 | 4.1 Million USD | 36.67% |
| 1996 | 3 Million USD | 76.47% |
| 1995 | 1.7 Million USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| 1991 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.06 Billion USD | 12.77% |
| 2024 Q2 | 1.06 Billion USD | -0.1% |
| 2024 Q3 | 873.89 Million USD | -6.52% |
| 2023 Q2 | 1.03 Billion USD | -13.88% |
| 2023 Q3 | 1.01 Billion USD | -1.64% |
| 2023 Q4 | 947.88 Million USD | -6.96% |
| 2023 Q1 | 1.2 Billion USD | -10.79% |
| 2023 FY | 947.88 Million USD | -29.7% |
| 2022 Q4 | 1.34 Billion USD | -10.47% |
| 2022 Q3 | 1.5 Billion USD | 9.22% |
| 2022 FY | 1.34 Billion USD | 45.97% |
| 2022 Q1 | 1.28 Billion USD | 38.96% |
| 2022 Q2 | 1.37 Billion USD | 7.43% |
| 2021 Q2 | 905.06 Million USD | -9.48% |
| 2021 Q3 | 963.17 Million USD | 6.42% |
| 2021 Q4 | 923.7 Million USD | -4.1% |
| 2021 FY | 923.7 Million USD | 1.68% |
| 2021 Q1 | 999.81 Million USD | 10.05% |
| 2020 Q4 | 908.48 Million USD | -8.29% |
| 2020 Q2 | 1.1 Billion USD | -12.55% |
| 2020 FY | 908.48 Million USD | -8.02% |
| 2020 Q1 | 1.26 Billion USD | 28.08% |
| 2020 Q3 | 990.55 Million USD | -10.46% |
| 2019 Q3 | 1 Billion USD | -2.81% |
| 2019 FY | 987.67 Million USD | -1.26% |
| 2019 Q1 | 1.12 Billion USD | 12.89% |
| 2019 Q2 | 1.03 Billion USD | -8.22% |
| 2019 Q4 | 987.67 Million USD | -1.95% |
| 2018 FY | 1 Billion USD | -20.68% |
| 2018 Q1 | 1.01 Billion USD | -19.39% |
| 2018 Q2 | 1.04 Billion USD | 2.32% |
| 2018 Q3 | 1.01 Billion USD | -2.23% |
| 2018 Q4 | 1 Billion USD | -1.64% |
| 2017 Q3 | 1.29 Billion USD | -1.11% |
| 2017 Q1 | 1.26 Billion USD | 5.13% |
| 2017 Q4 | 1.26 Billion USD | -2.27% |
| 2017 Q2 | 1.3 Billion USD | 3.08% |
| 2017 FY | 1.26 Billion USD | 4.73% |
| 2016 Q1 | 1.22 Billion USD | 4.44% |
| 2016 Q4 | 1.2 Billion USD | 10.76% |
| 2016 Q3 | 1.08 Billion USD | -5.95% |
| 2016 FY | 1.2 Billion USD | 2.91% |
| 2016 Q2 | 1.15 Billion USD | -5.41% |
| 2015 Q3 | 1.14 Billion USD | 4.11% |
| 2015 FY | 1.17 Billion USD | 30.15% |
| 2015 Q2 | 1.09 Billion USD | 4.52% |
| 2015 Q1 | 1.04 Billion USD | 16.74% |
| 2015 Q4 | 1.17 Billion USD | 2.45% |
| 2014 Q1 | 466.14 Million USD | 8.81% |
| 2014 FY | 899 Million USD | 109.85% |
| 2014 Q4 | 899 Million USD | 24.0% |
| 2014 Q3 | 725 Million USD | 35.77% |
| 2014 Q2 | 534 Million USD | 14.56% |
| 2013 FY | 428.39 Million USD | 99.72% |
| 2013 Q3 | 398.84 Million USD | 7.94% |
| 2013 Q2 | 369.52 Million USD | 40.9% |
| 2013 Q1 | 262.26 Million USD | 22.27% |
| 2013 Q4 | 428.39 Million USD | 7.41% |
| 2012 FY | 214.5 Million USD | -12.95% |
| 2012 Q2 | 246.96 Million USD | -3.98% |
| 2012 Q3 | 234.73 Million USD | -4.95% |
| 2012 Q1 | 257.19 Million USD | 4.37% |
| 2012 Q4 | 214.5 Million USD | -8.62% |
| 2011 Q4 | 246.41 Million USD | 56.32% |
| 2011 Q2 | 136.4 Million USD | 4.4% |
| 2011 Q1 | 130.66 Million USD | -1.97% |
| 2011 FY | 246.41 Million USD | 84.89% |
| 2011 Q3 | 157.63 Million USD | 15.57% |
| 2010 Q1 | 162.28 Million USD | 31.0% |
| 2010 FY | 133.28 Million USD | 7.58% |
| 2010 Q3 | 130.4 Million USD | -5.89% |
| 2010 Q4 | 133.28 Million USD | 2.21% |
| 2010 Q2 | 138.55 Million USD | -14.62% |
| 2009 FY | 123.88 Million USD | -20.83% |
| 2009 Q1 | 171.19 Million USD | 9.4% |
| 2009 Q2 | 160.28 Million USD | -6.37% |
| 2009 Q3 | 147.88 Million USD | -7.73% |
| 2009 Q4 | 123.88 Million USD | -16.23% |
| 2008 Q2 | 164.06 Million USD | 12.2% |
| 2008 Q1 | 146.22 Million USD | 85.84% |
| 2008 FY | 156.47 Million USD | 98.87% |
| 2008 Q4 | 156.47 Million USD | -7.87% |
| 2008 Q3 | 169.85 Million USD | 3.53% |
| 2007 Q2 | 90.53 Million USD | 10.18% |
| 2007 FY | 78.68 Million USD | 1004.32% |
| 2007 Q1 | 82.17 Million USD | 1053.33% |
| 2007 Q3 | 83.9 Million USD | -7.33% |
| 2007 Q4 | 78.68 Million USD | -6.22% |
| 2006 Q3 | 7.29 Million USD | -2.15% |
| 2006 FY | 7.12 Million USD | 1193.1% |
| 2006 Q4 | 7.12 Million USD | -2.26% |
| 2006 Q1 | - USD | -100.0% |
| 2006 Q2 | 7.45 Million USD | 0.0% |
| 2005 Q1 | 526 Thousand USD | -68.75% |
| 2005 Q2 | 531 Thousand USD | 0.95% |
| 2005 Q3 | 542 Thousand USD | 2.07% |
| 2005 Q4 | 551 Thousand USD | 1.66% |
| 2005 FY | 551 Thousand USD | -67.26% |
| 2004 FY | 1.68 Million USD | 31.48% |
| 2004 Q4 | 1.68 Million USD | 43.36% |
| 2004 Q3 | 1.17 Million USD | -3.37% |
| 2004 Q1 | 1.39 Million USD | 9.14% |
| 2004 Q2 | 1.21 Million USD | -13.03% |
| 2003 Q4 | 1.28 Million USD | 161.76% |
| 2003 FY | 1.28 Million USD | 31.55% |
| 2003 Q1 | 984 Thousand USD | 1.13% |
| 2003 Q2 | 482 Thousand USD | -51.02% |
| 2003 Q3 | 489 Thousand USD | 1.45% |
| 2002 Q1 | 8.39 Million USD | 0.21% |
| 2002 Q2 | 950 Thousand USD | -88.69% |
| 2002 Q3 | 964 Thousand USD | 1.47% |
| 2002 Q4 | 973 Thousand USD | 0.93% |
| 2002 FY | 973 Thousand USD | -88.39% |
| 2001 Q2 | 8.49 Million USD | 0.26% |
| 2001 Q4 | 8.38 Million USD | -1.49% |
| 2001 Q3 | 8.5 Million USD | 0.14% |
| 2001 Q1 | 8.47 Million USD | 0.01% |
| 2001 FY | 8.38 Million USD | -1.09% |
| 2000 Q2 | 3.37 Million USD | -4.06% |
| 2000 Q3 | 8.52 Million USD | 152.52% |
| 2000 FY | 8.47 Million USD | 135.33% |
| 2000 Q4 | 8.47 Million USD | -0.62% |
| 2000 Q1 | 3.51 Million USD | -2.25% |
| 1999 Q1 | 9.8 Million USD | 4.26% |
| 1999 Q2 | 9.5 Million USD | -3.06% |
| 1999 FY | 3.6 Million USD | -61.7% |
| 1999 Q3 | 8.4 Million USD | -11.58% |
| 1999 Q4 | 3.6 Million USD | -57.14% |
| 1998 Q4 | 9.4 Million USD | 526.67% |
| 1998 Q1 | 2.6 Million USD | -36.59% |
| 1998 Q2 | 2.5 Million USD | -3.85% |
| 1998 Q3 | 1.5 Million USD | -40.0% |
| 1998 FY | 9.4 Million USD | 129.27% |
| 1997 Q3 | 3.5 Million USD | -22.22% |
| 1997 Q4 | 4.1 Million USD | 17.14% |
| 1997 Q1 | 4.5 Million USD | 50.0% |
| 1997 FY | 4.1 Million USD | 36.67% |
| 1997 Q2 | 4.5 Million USD | 0.0% |
| 1996 Q4 | 3 Million USD | 0.0% |
| 1996 FY | 3 Million USD | 76.47% |
| 1996 Q1 | - USD | -100.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q3 | 3 Million USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 Q4 | 1.7 Million USD | 0.0% |
| 1995 Q3 | 1.7 Million USD | 0.0% |
| 1995 Q2 | 1.7 Million USD | 0.0% |
| 1995 FY | 1.7 Million USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -7810.206% |
| Accuray Incorporated | 172.15 Million USD | -450.594% |
| Align Technology, Inc. | 96.96 Million USD | -877.518% |
| Elevance Health Inc. | 25.12 Billion USD | 96.227% |
| AxoGen, Inc. | 69.29 Million USD | -1267.95% |
| Boston Scientific Corporation | 9.09 Billion USD | 89.58% |
| CVS Health Corporation | 79.38 Billion USD | 98.806% |
| Cardinal Health, Inc. | 5.6 Billion USD | 83.101% |
| Centene Corporation | 17.69 Billion USD | 94.644% |
| DaVita Inc. | 11.11 Billion USD | 91.473% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 97.736% |
| Hologic, Inc. | 2.53 Billion USD | 62.602% |
| Humana Inc. | 10.21 Billion USD | 90.719% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | 84.08% |
| Masimo Corporation | 970 Million USD | 2.28% |
| McKesson Corporation | 5.47 Billion USD | 82.678% |
| Patterson Companies, Inc. | 762.94 Million USD | -24.24% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | 82.345% |
| ResMed Inc. | 873.93 Million USD | -8.461% |
| Henry Schein, Inc. | 2.74 Billion USD | 65.418% |
| Teladoc Health, Inc. | 1.59 Billion USD | 40.47% |
| Universal Health Services, Inc. | 5.36 Billion USD | 82.338% |
| Veeva Systems Inc. | 55.77 Million USD | -1599.471% |
| Baxter International Inc. | 14.36 Billion USD | 93.401% |
| Becton, Dickinson and Company | 15.87 Billion USD | 94.031% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -955.546% |
| Danaher Corporation | 19.35 Billion USD | 95.103% |
| Stryker Corporation | 12.99 Billion USD | 92.706% |
| Medtronic plc | 24.96 Billion USD | 96.203% |